Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
AstraZeneca
UBS
Farmers Insurance
Dow
Moodys
Healthtrust
Cerilliant
Citi

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,683,051

« Back to Dashboard

Which drugs does patent 7,683,051 protect, and when does it expire?

Patent 7,683,051 protects DUAVEE and is included in one NDA.

This patent has twenty-three patent family members in twenty-one countries.
Summary for Patent: 7,683,051
Title:Crystalline polymorph of bazedoxifene acetate
Abstract: The present invention is directed to a crystalline polymorph of bazedoxifene acetate, compositions containing the same, preparations thereof, and uses thereof.
Inventor(s): Demerson; Christopher (Kirkland, CA), Iera; Silvio (Montreal, CA), Ali; Kadum A. (Congers, NY)
Assignee: Wyeth (Madison, NJ)
Application Number:11/100,983
Patent Claim Types:
see list of patent claims
Compound; Composition; Use; Formulation;

Drugs Protected by US Patent 7,683,051

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Wyeth Pharms Pfizer DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247-001 Oct 3, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE ➤ Try a Free Trial
Wyeth Pharms Pfizer DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247-001 Oct 3, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,683,051

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Singapore 151331 ➤ Try a Free Trial
Russian Federation 2006132180 ➤ Try a Free Trial
Peru 06762006 ➤ Try a Free Trial
Panama 8629101 ➤ Try a Free Trial
Norway 20065052 ➤ Try a Free Trial
South Korea 20060135866 ➤ Try a Free Trial
Japan 2009035535 ➤ Try a Free Trial
Japan 2007532560 ➤ Try a Free Trial
Israel 178236 ➤ Try a Free Trial
Guatemala 200500078 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Cantor Fitzgerald
Mallinckrodt
Moodys
Teva
AstraZeneca
Johnson and Johnson
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot